Navigation Links
Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
Date:3/19/2008

yde dehydrogenase ("ALDH2") deficiency and nephropathic cystinosis.

For additional information, please visit http://www.raptorpharma.com.

About Patheon Pharmaceuticals Inc.

Patheon (TSX: PTI) is a leading global provider of drug development and manufacturing services to the international pharmaceutical industry. The Company operates a network of 12 facilities in the United States, Canada and Europe, employing more than 4,650 people and serving a global client base of 250 pharmaceutical and biotechnology companies. For further information about Patheon, please visit http://www.patheon.com or contact the company at info@patheon.com or (905) 821-4001.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limited to the following statements: the Company's ability to initiate a Phase 2a study of Cysteamine or Delayed Release Cysteamine in NASH patients in 2008, develop an oral formulation of 4MP, develop clinical assays for the oral formulation of 4MP and initiate a clinical trial for the oral formulation of 4MP in the second half of 2008. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent our forward looking statements from fruition include that we may be unsuccessful in developing any products or acquiring products; that our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; that we are unable
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Raptor Pharmaceuticals Acquires Orphan Clinical Program
2. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
3. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
4. Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results
5. MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
7. NPS Pharmaceuticals Reports 2007 Financial Results
8. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
9. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
10. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
11. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... (PRWEB) August 19, 2014 Shimadzu ... chromatography systems, Prominence-i and Nexera-i, adding to the ... Combining excellent functionality, an intuitive operating environment, and ... a more efficient workflow for conventional to ultra-high-speed ... innovative, intuitive and intelligent design so users can ...
(Date:8/19/2014)... -- Research and Markets  has announced the addition of ... Business Report" report to their offering. ... Cells (SOFCs) in US$ Thousands. The report provides separate comprehensive ... Europe , Asia-Pacific , and ... the period 2012 through 2020. Market data and analytics are ...
(Date:8/19/2014)... , Aug. 19, 2014 CSSi, the ... industry, recently announced the formation of the company,s Medical ... announce the addition of Dr. William E. Gannon, ... http://photos.prnewswire.com/prnh/20140818/136957 The MCAB, with ... variety of therapeutic areas and set strategic goals for ...
(Date:8/19/2014)... Sales Horizons, a leader in sales ... sales skills training course to help companies develop ... staff spend the majority of their time on client ... or physician practice – providing support and education to ... Sales Horizons believes clinical staff are and should be ...
Breaking Biology Technology:Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3
... speculate that the Greater Madison area, while a key ... the "critical mass" of talent, innovation, and specialization necessary ... sustained growth. , ,But as area biotech leaders and ... discovery tool provider, Caden Biosciences , to a ...
... Madison, Wis. - The Madison-based Imago Scientific ... to Iowa State University's College of Engineering ... High Throughput Atom-Scale Analysis. , ,The lab will be ... Discovery, which is led by Balaji Narasimhan, an associate ...
... to the future growth and success of the state ... state boasts significant competitive advantages in terms of talent, ... mass needed to compete with our most significant competition ... resources so vital to building and sustaining economic growth. ...
Cached Biology Technology:Caden Biosciences may signal critical mass 2Regional collaboration is key to state's future 2Regional collaboration is key to state's future 3
(Date:8/20/2014)... approximately 3 million infants, a team of scientists across ... Massachusetts Medical School, have shown that newborn screening for ... public health newborn screening programs. Data from 11 newborn ... the Journal of the American Medical Association ... newborns is higher than previously thought and believed to ...
(Date:8/20/2014)... scientists have discovered that acral melanomas the rare type ... are genetically distinct from other more common types of ... in the journal Pigment Cell & Melanoma Research . ... hands, soles of the feet, nail-beds and other hairless parts ... it,s not caused by UV damage from the sun. , ...
(Date:8/20/2014)... pepper causes a burning spiciness that is irresistible to ... pepper,s effect are using their findings to develop a ... can be caused by inflammation or other problems. They ... tested in clinical trials, in ACS, Journal of ... that decades ago, scientists had pegged a compound called ...
Breaking Biology News(10 mins):Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3Scientists learn more about rare skin cancer that killed Bob Marley 2
... U.S. Department of Energy this month awarded a group ... develop bacteria that can turn the methane in natural ... we,re shooting for will have the same fuel characteristics ... professor of chemical engineering and microbiology. "It can be ...
... Innes Centre will publish the first RNA sequence data on the ... will release the data via a website to a system designed ... used to crowdsource expertise during the 2011 E. coli ... able to access the RNA sequence and start to analyse it ...
... University of Illinois at Urbana-Champaign has received a fiveyear, $5.7 ... in corn. These strains have the potential to combat the ... yield. A team at the Institute for Genomic Biology in ... lead the research. "Ozone can cause major damage ...
Cached Biology News:Energy Deptartment funds UW project to turn wasted natural gas into diesel 2Crowdsourcing to kickstart comeback from ash dieback 2University of Illinois receives grant to study ozone resistance in corn 2
Assay Diluent, 10 L...
Assay Diluent Trial Pack, 4 x 100 mL...
HRP Monoclonal-Goat Diluent - 5X Concentrate, 25 mL...
SpectroQuest single beam 1.8nm UV/Vis spectrophotometer; stand-alone unit...
Biology Products: